Hepatocellular Carcinoma–Circulating Tumor Cells Expressing PD‐L1 Are Prognostic and Potentially Associated With Response to Checkpoint Inhibitors

Hepatocellular carcinoma (HCC) is a leading cause of mortality. Checkpoint inhibitors of programmed cell death protein‐1 (PD‐1) and programmed death‐ligand 1 (PD‐L1) have shown great efficacy, but lack biomarkers that predict response. Circulating tumor cells (CTCs) have promise as a liquid‐biopsy b...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Paul Winograd, Shuang Hou, Colin M. Court, Yi‐Te Lee, Pin‐Jung Chen, Yazhen Zhu, Saeed Sadeghi, Richard S. Finn, Pai‐Chi Teng, Jasmin J. Wang, Zhicheng Zhang, Hongtao Liu, Ronald W. Busuttil, James S Tomlinson, Hsian‐Rong Tseng, Vatche G. Agopian
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wolters Kluwer Health/LWW 2020-10-01
Colecção:	Hepatology Communications
Acesso em linha:	https://doi.org/10.1002/hep4.1577
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!